Suppr超能文献

[精神分裂症中的抑郁症状]

[Depressive symptoms in schizophrenia].

作者信息

Grüber L, Falkai P, Hasan A

出版信息

Fortschr Neurol Psychiatr. 2015 Apr;83(4):238-46; quiz 247-8. doi: 10.1055/s-0034-1399347. Epub 2015 Apr 20.

Abstract

Patients with schizophrenia suffer frequently from comorbid depressive symptoms. However, there is a paucity of studies regarding prevalence, clinical diagnostic and treatment in the field. For this review, we performed a focused literature analysis to identify recommendation for the treatment and diagnosis of schizophrenia with comorbid depression. Furthermore, we searched different schizophrenia guidelines for specific treatment recommendations. Due to the complex and heterogeneous picture of depressive symptoms in schizophrenia, the application of standardized assessment tools is recommended. For these purposes, the CDSS (Calgary depression rating scale for Schizophrenia) is such an established tool. In summary, there is only limited evidence for specific treatment recommendations. A change in antipsychotic treatment should usually be preferred before an antidepressant is introduced. In the group of antidepressants, SSRI seem to have some advantages, but most clinical and scientific experience is available for tricyclic antidepressants. Due to the limited original contributions and studies with sufficient methodology, further interventional trials are needed to give specific recommendations with high evidence grades.

摘要

精神分裂症患者经常伴有抑郁症状。然而,该领域关于患病率、临床诊断和治疗的研究较少。在本综述中,我们进行了重点文献分析,以确定对伴有抑郁症的精神分裂症的治疗和诊断建议。此外,我们检索了不同的精神分裂症指南以获取具体的治疗建议。由于精神分裂症中抑郁症状的情况复杂且多样,建议应用标准化评估工具。为此,CDSS(卡尔加里精神分裂症抑郁评定量表)就是这样一种成熟的工具。总之,关于具体治疗建议的证据有限。在引入抗抑郁药之前,通常应优先考虑改变抗精神病药物治疗。在抗抑郁药组中,SSRI似乎有一些优势,但三环类抗抑郁药有最多的临床和科学经验。由于原始研究贡献有限且方法学充分的研究较少,需要进一步的干预试验以给出具有高证据等级的具体建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验